Monograph

C01EA01 - Alprostadil

Not porphyrinogenic

Rationale

Endogenous prostaglandin. No relevant CYP metabolism.

Chemical description

Prostaglandin E1.

Therapeutic characteristics

Alprostadil is used mainly in congenital heart disease and in erectile dysfunction.

Metabolism and pharmacokinetics

Metabolized in the lungs and excreted within 24 hours.

Preclinical data

None

Personal communication

None

Published experience

None

Similar drugs

Explore alternative drugs in similar therapeutic classes C01E / C01EA or go back.

Tradenames and packages

From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Netherlands